Literature DB >> 18512969

Efficient synthesis, liquid chromatography purification, and tandem mass spectrometric characterization of estrogen-modified DNA bases.

Qiang Zhang1, Michael L Gross.   

Abstract

Estrogens are metabolized to active quinones that modify DNA and may lead to various cancers. To extend the analytical methodology for estrogen-modified purine bases, we report here a simple modification to existing synthetic procedures that use 2-iodoxybenzoic acid (IBX) as the oxidizing agent for the reference material and putative biomarker, 4-hydroxyestrone-1-N3adenine (4-OH-E1-1-N3Ade). The reaction leads to two catechol estrogen quinones, CE1-2,3-Q and CE1-3,4-Q, both of which react via Michael additions to afford 4-OH-E1-1-N3Ade and other DNA adducts. Liquid chromatography separation permits the isolation of high-purity 4-OH-E1-1-N3Ade. With this method, we also prepared single 13C and uniformly 15N (U-15N) labeled 4-OH-E1-1-N3Ade with 8-13C-labeled Ade and U-15N-labeled adenosine 5'-monophosphate (AMP). The approach is also effective for the synthesis of 4-hydroxyestradiol-1-N3adenine, 4-OH-E2-1-N3Ade, and 4-hydroxyestrone(estradiol)-1-N7guanine, 4-OH-E1(E2)-1-N7Gua. The tandem mass spectra (MS2 and MS3) of 4-OH-E1-(unlabeled, 8-13C-, and U-15N-labeled)1-N3Ade and accurate mass measurements for MS2 product ions allow us to assign unambiguously the formula of fragments and delineate the fragmentation pathways. One important reaction is dehydration, which occurs at the ketone oxygen in the C-17 position of estrone. Another is loss of NH3, an ubiquitous process for purines and modified purines, which is affected by the steroid modification. Evidence from MS/MS supports the migration of H-atom(s) from estrone in the loss of NH3. An interesting interaction occurs between the steroid and the Ade in the modified base, promoting loss of CH2NH, a loss that distinguishes modified Ade from unmodified Ade. The synthesis of a stable isotope-labeled 4-OH-E1-1-N3Ade and the understanding of the fragmentation processes will enable studies aimed at the etection of naturally occurring 4-OH-E1-1-N3Ade in biological samples.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18512969      PMCID: PMC2656942          DOI: 10.1021/tx800067s

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  28 in total

Review 1.  Estrogen and the risk of breast cancer.

Authors:  M Clemons; P Goss
Journal:  N Engl J Med       Date:  2001-01-25       Impact factor: 91.245

Review 2.  To block estrogen's synthesis or action: that is the question.

Authors:  Richard J Santen
Journal:  J Clin Endocrinol Metab       Date:  2002-07       Impact factor: 5.958

Review 3.  Hormonal carcinogenesis.

Authors:  B E Henderson; H S Feigelson
Journal:  Carcinogenesis       Date:  2000-03       Impact factor: 4.944

Review 4.  Role of DNA adducts in hormonal carcinogenesis.

Authors:  J G Liehr
Journal:  Regul Toxicol Pharmacol       Date:  2000-12       Impact factor: 3.271

5.  Analysis of potential biomarkers of estrogen-initiated cancer in the urine of Syrian golden hamsters treated with 4-hydroxyestradiol.

Authors:  R Todorovic; P Devanesan; S Higginbotham; J Zhao; M L Gross; E G Rogan; E L Cavalieri
Journal:  Carcinogenesis       Date:  2001-06       Impact factor: 4.944

Review 6.  Hormones and hormone antagonists: mechanisms of action in carcinogenesis of endometrial and breast cancer.

Authors:  T Flötotto; S Djahansouzi; M Gläser; B Hanstein; D Niederacher; C Brumm; M W Beckmann
Journal:  Horm Metab Res       Date:  2001-08       Impact factor: 2.936

Review 7.  Role of quinones in toxicology.

Authors:  J L Bolton; M A Trush; T M Penning; G Dryhurst; T J Monks
Journal:  Chem Res Toxicol       Date:  2000-03       Impact factor: 3.739

8.  Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female ACI rat mammary gland in vivo.

Authors:  Kai-Ming Li; Rosa Todorovic; Prabu Devanesan; Sheila Higginbotham; Harald Köfeler; Ragulan Ramanathan; Michael L Gross; Eleanor G Rogan; Ercole L Cavalieri
Journal:  Carcinogenesis       Date:  2003-10-24       Impact factor: 4.944

Review 9.  Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis.

Authors:  W Yue; R J Santen; J-P Wang; Y Li; M F Verderame; W P Bocchinfuso; K S Korach; P Devanesan; R Todorovic; E G Rogan; E L Cavalieri
Journal:  J Steroid Biochem Mol Biol       Date:  2003-09       Impact factor: 4.292

Review 10.  Potential mechanisms of estrogen quinone carcinogenesis.

Authors:  Judy L Bolton; Gregory R J Thatcher
Journal:  Chem Res Toxicol       Date:  2007-12-04       Impact factor: 3.739

View more
  5 in total

1.  Estrogen carcinogenesis: specific identification of estrogen-modified nucleobase in breast tissue from women.

Authors:  Qiang Zhang; Rebecca L Aft; Michael L Gross
Journal:  Chem Res Toxicol       Date:  2008-08-02       Impact factor: 3.739

2.  Structural determinant of chemical reactivity and potential health effects of quinones from natural products.

Authors:  Tingting Tu; Daryl Giblin; Michael L Gross
Journal:  Chem Res Toxicol       Date:  2011-08-02       Impact factor: 3.739

3.  Characterization of oligodeoxynucleotides and modifications by 193 nm photodissociation and electron photodetachment dissociation.

Authors:  Suncerae I Smith; Jennifer S Brodbelt
Journal:  Anal Chem       Date:  2010-09-01       Impact factor: 6.986

4.  Hybrid activation methods for elucidating nucleic acid modifications.

Authors:  Suncerae I Smith; Jennifer S Brodbelt
Journal:  Anal Chem       Date:  2010-12-09       Impact factor: 6.986

5.  Balance of beneficial and deleterious health effects of quinones: a case study of the chemical properties of genistein and estrone quinones.

Authors:  Qiang Zhang; Tingting Tu; D André d'Avignon; Michael L Gross
Journal:  J Am Chem Soc       Date:  2009-01-28       Impact factor: 15.419

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.